Provided by Tiger Trade Technology Pte. Ltd.

Senti Biosciences, Inc.

0.3886
-0.0474-10.87%
Post-market: 0.3836-0.0050-1.29%19:57 EDT
Volume:757.55K
Turnover:304.63K
Market Cap:12.10M
PE:-0.23
High:0.4400
Open:0.4360
Low:0.3600
Close:0.4360
52wk High:2.88
52wk Low:0.3331
Shares:31.14M
Float Shares:14.58M
Volume Ratio:2.71
T/O Rate:5.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7136
EPS(LYR):-2.7326
ROE:-466.46%
ROA:-65.57%
PB:-3.56
PE(LYR):-0.14

Loading ...

Press Release: Senti Biosciences Holdings Reports First Quarter 2026 Financial Results and Highlights Advancement of SENTI-202 Program into Pivotal Phase

Dow Jones
·
May 14

Senti Biosciences Holdings Announces Positive FDA Rmat Meeting on Registrational Clinical and Cmc Strategy for Senti-202 in Relapsed/Refractory Aml, Along With Important Efficacy and Durability Updates on the Senti-202 Clinical Program

THOMSON REUTERS
·
May 14

Senti Biosciences Holdings Inc - Senti-202 Future Manufacturing to Use Donor X Phenotype

THOMSON REUTERS
·
May 14

Senti Biosciences deregisters common stock under Exchange Act Form 15

Reuters
·
May 09

Senti Biosciences Inc - Enters Agreement to Issue up to $40 Mln in Senior Secured Convertible Notes - SEC Filing

THOMSON REUTERS
·
May 02

Senti Biosciences signs securities purchase deal for up to $40 million convertible notes

Reuters
·
May 02

Senti Bio CEO Timothy Lu to present logic-gated NK cell therapy at AACR meeting

Reuters
·
Apr 13

BRIEF-Senti Biosciences Announces Holding Company Reorganization Effective By April 16, 2026 - SEC Filing

Reuters
·
Apr 02

Senti Biosciences plans tax-free holding company reorganization by April 16

Reuters
·
Apr 02

Senti Bio study in Cell Systems advances NOT-gated CAR design for T and NK therapies

Reuters
·
Apr 01

Senti Biosciences Is Maintained at Buy by Chardan Capital

Dow Jones
·
Mar 30

Chardan Cuts Price Target on Senti Biosciences to $11 From $13, Keeps Buy Rating

MT Newswires Live
·
Mar 30

Senti Biosciences Q4 EPS $(0.53) Misses $(0.48) Estimate, Sales $22.000K Miss $666.667K Estimate

Benzinga Earnings
·
Mar 27

Senti Biosciences Q4 revenue misses analyst estimates

Reuters
·
Mar 27

BRIEF-Senti Biosciences Q4 Net Income USD -14.467 Million

Reuters
·
Mar 27

Senti Biosciences Q4 EPS USD -0.53

THOMSON REUTERS
·
Mar 27

Senti Biosciences Q4 Revenue USD 22 Thousand

THOMSON REUTERS
·
Mar 27

Press Release: Senti Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update

Dow Jones
·
Mar 27

Senti Biosciences to present SENTI-202 Phase 1 data at 11th Annual Innate Killer Conference

Reuters
·
Mar 23

Senti Biosciences Inc expected to post a loss of 41 cents a share - Earnings Preview

Reuters
·
Mar 17